CTI BioPharma Corp (fka CTIC)

[geocam]

$53 million cash and a 117,831 share reduction?



ihub 8k
http://ih.advfn.com/p.php?pid=nmona&article=71865291&symbol=CTIC

request from CONSOB, the Italian securities regulatory authority, CTI BioPharma Corp. (the “Company”) issued a press release in Italy on June 30, 2016 providing certain requested financial information for the month ended May 31, 2016 and other information (the “Monthly Italian Press Release”).

Exhibit 99.1 is an English translation of the financial information requested by CONSOB


http://www.consob.it/mainen/consob/what/what.html?symblink=/mainen/consob/what/index.html

The Commissione Nazionale per le Società e la Borsa (CONSOB) is the public authority responsible for regulating the Italian financial markets.

Its activity is aimed at the protection of the investing public.
In this connection, the CONSOB is the competent authority for ensuring

• transparency and correct behaviour by financial market participants;
• disclosure of complete and accurate information to the investing public by listed companies;
• accuracy of the facts represented in the prospectuses related to offerings of transferable securities to the investing public;
• compliance with regulations by auditors entered in the Special Register


It conducts investigations with respect to potential infringements of insider dealing and market manipulation law.

Exhibit 99.1
https://www.sec.gov/Archives/edgar/data/891293/000089129316000169/ex991consobmonthly201605.htm

The total estimated and unaudited net financial standing of CTI Parent Company as of May 31, 2016 was $53.7 million.

During the month of May 2016, the Company’s common stock, no par value (the “Common Stock”), outstanding decreased by 117,831 shares. As a result, the number of issued and outstanding shares of Common Stock as of May 31, 2016 was 282,812,236.